AAV5 VP3 antibody (AA 525-550)

Catalog No. ABIN1732612

This Rabbit Polyclonal antibody specifically detects AAV5 VP3 in WB. It exhibits reactivity toward Adeno-Associated Virus 5 (AAV-5).

Quick Overview for AAV5 VP3 antibody (AA 525-550) (ABIN1732612)

Target: AAV5 VP3 (Adeno-Associated Virus 5, VP3 (AAV5 VP3))

Reactivity: Adeno-Associated Virus 5 (AAV-5)

Host: Rabbit

Clonality: Polyclonal

Application: Western Blotting (WB)

Product Details anti-AAV5 VP3 Antibody

Binding Specificity: AA 525-550

Specificity: Reacts with capsid VP3 protein of Adeno Assoicated Virus 5

Purification: Antigen affinity purified

Immunogen: Synthetic peptide within residues 525-550 of 80 kDa capsid VP3 protein of AAV5.

Isotype: IgG

Application Details

Application Notes:

Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB(1:500-1:1000)

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.0 mg/mL

Buffer: PBS, Sodium azide 0.02 %

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Antibodies are guaranteed for 6 month from date of receipt.

Expiry Date: 6 months

Target Details for AAV5 VP3

Target: AAV5 VP3 (Adeno-Associated Virus 5, VP3 (AAV5 VP3))

Alternative Name: AAV5 VP3

Target Type: Viral Protein

Background: Adenoviruses are DNA viruses that cause upper respiratory tract infections, conjunctivitis, and other infections in humans. Adenoviruses were discovered in 1953. About 47 different types have been identified since then, and about half of them are believed to cause human diseases. Infants and children are most commonly affected by adenoviruses. Adenovirus infections can occur throughout the year, but seem to be most common from fall to spring. Adenoviruses are responsible for 3-5 % of acute respiratory infections in children and 2 % of respiratory illnesses in adults.